AWHP commends the recent bipartisan action to reintroduce the Treat and Reduce Obesity Act (TROA) in the House. If passed, TROA would expand needed coverage for #obesity care for millions of older Americans who rely on Medicare. Read our full statement: womenshealthandprevention.org/awhp-commends-…

ICYMI: The Weill Cornell Medicine Columbia University #Obesity #Medicine Course is now available on-demand 👉 columbiacme.rievent.com/s/catalog?orde… It fulfills the 60 credits you need to sit for the American Board of Obesity Medicine board exam I am biased as a course director, but I think ours gives the best value 🙃

THIS IS HUGE. Massively important tips at 14:30 and 19:00: 👉 "Can the patient take Mounjaro?" SAY YES YES YES Mounjaro and Zepbound are the same! They are both tirzepatide I've submitted some PAs saying "No" to this question assuming no coverage because they don't have

I have innumerable patients who want to shift salary contributions, from insurance premiums to HSA, that they can use to buy #Zepbound out of pocket Patients are asking themselves, what is better for my #health? #Hellthinsurance or medical treatment for #obesity? Treating

A first move by a state to crack down on the vertical integration monopoly of CVS Pharmacy CVS Health and #PBM CVS Caremark 👉Sarah Huckabee Sanders governor of Arkansas passes Act 624 which prohibits pharmacies from being PBMs newsweek.com/cvs-arkansas-p…

I can't tell you how excited I am about this #PBM Reform

Hormone Replacement Therapy (HRT) has long been an important treatment option for women to alleviate symptoms of menopause, among other potential health benefits. Over the last two decades, however, HRT has been surrounded by confusing narratives about potential risks. We're

Sharing with permission: "#Zepbound has made my #weight slash food relationships 'low drama'" I love making weight maintenance low maintenance. #obesity #medicine #weightmanagement #weightloss

Many moons ago, Kevin Hall and I talked about a book we both wished existed. No fads, no weight loss hacks—just the nutrition and metabolism science. I’m thrilled to announce that we wrote it! Out September 23 Avery Books & available now for pre-order. penguinrandomhouse.com/books/671334/f…

We've been slowly uptitrating Ozempic by using "clicks" for a while knowing it would improve tolerability. Great to see we now have data to back this method up!

Yes, #GLP1s may ⬆️testosterone levels, likely through #weightloss: healthline.com/health-news/gl… Healthline

😮 Wow. Connecticut just passed a law effectively pursuing “eminent domain” of #GLP1s 👉finance.yahoo.com/news/connectic… “The new law calls for the Commissioner of Social Services to petition the US Health and Human Services Department (HHS) Secretary Robert F. Kennedy Jr. to exercise

Such an important topic to face head on I’m on both sides of the tension as an advisor to Lilly/Novo and Ro And I’m sure Dr. Saunders will moderate this panel from the evidence based, clinician’s lens as she always has: 👉 Scalability and personalization are a false dichotomy

To reemphasize, human studies have not found a meaningful difference in how our bodies handle fructose vs sucrose 👉 pubmed.ncbi.nlm.nih.gov/33684506/ 👉 pubmed.ncbi.nlm.nih.gov/26338891/ However, short term studies don’t inform us on long term effects. Such as: what happens to #health next when

ICYMI: The EMA has suggested to add NAION to the label for semaglutide #Ozempic But American professional societies think this is an overreach 👉 aao.org/newsroom/news-… TriNetX data found no association: ajo.com/article/S0002-… A meta-analysis of RCTs found no association:

Hi Matt Lesser , this was a fantastic #interview on your efforts to reform prescription drug costs Clarifying Q: You stated that the Prescription Drug Task Force bill requires #PBMs to act in the best interest of the "customer"-- 👉Is that the patient? 👉Or the "health

Most people don’t realize this: the net price (what manufacturers actually take home) for many on-formulary GLP-1s in the U.S. is now approaching the prices paid in other developed countries. And yet, thanks to the PBM racket—and the army of middlemen taking their cut—the list

If you’re in Delhi, Chennai, or Mumbai in the next 4 days, say 👋! I’m doing 6 lectures in 3 cities on the cardiometabolic data for semaglutide, focusing on SELECT and SCORE 👉 nejm.org/doi/full/10.10… 👉 novonordisk.ca/content/dam/nn…